We delve into ICER’s influence on drug pricing and access in the US. We also explore the importance of maximising engagement with ICER for favourable pricing and access outcomes.
Read More
We're thrilled to announce that Mtech Access will be exhibiting at the ISPOR conference May 5–8 in Atlanta, Georgia, USA! As regular attendees of ISPOR Europe, we're excited to be...
Read More
We bring together specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024-25. Jump in, as our experts give their hot-take on each trend, sharing their perspectives on what’s happening in these areas.
What actions can you take in light of ISPOR’s top 10 HEOR trends? What impact may these issues have on your HEOR and Market Access strategy?
We’re delighted to announce that we will be exhibiting at ISPOR Europe in Copenhagen over the 13th–15th November 2023. Visit our virtual booth Meet the team Research & Posters Meet...
Read More
Araadhna Sinha tells us about her research evaluating NICE’s new disease severity modifier. Including the impact it could have had on past Health Technology Assessments.
Edyta Ryczek tells us about her research into the inclusion of Carer Health-Related Quality of Life measures in NICE Appraisals
Elizabeth Thurgar tells us about her ISPOR poster reviewing fast-track appraisals at NICE and the evolution of cost comparison
Laura Mathers tells us about her research assessing surrogate endpoints and their impact on HTA recommendations – ISPOR Posters
Olivia Dickinson tells us about her research reviewing oncology submissions to NICE to see how often QoL data is accepted.
